HA
SGEN

Harfst & Associates’s Seagen Inc. Common Stock SGEN Stock Holding History

Harfst & Associates’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,287
Closed -$404K – 109
2022
Q2 		$404K Sell
2,287
-1,295
-36% -$187K 0.11% 93
2022
Q1 		$515K Buy
3,582
+628
+21% +$85K 0.12% 97
2021
Q4 		$456K Sell
2,954
-537
-15% -$89.9K 0.12% 94
2021
Q3 		$592K Buy
3,491
+40
+1% +$6.22K 0.16% 89
2021
Q2 		$544K Sell
3,451
-385
-10% -$57.2K 0.16% 100
2021
Q1 		$532K Buy
+3,836
New +$618K 0.16% 103

Other funds holding SGEN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harfst & Associates's SGEN Position: Q3 2022 in Review

Harfst & Associates sold out of Seagen Inc. Common Stock (SGEN) in Q3 2022, closing a stake of 2,287 shares — an estimated $404K sold.

Harfst & Associates first reported a position in SGEN in Q1 2021 and held it in 6 quarters. The position peaked at $592K in Q3 2021. 539 funds tracked by Wall St. Rank hold SGEN as of Q3 2022.

  • Harfst & Associates reported no remaining Seagen Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Harfst & Associates sold 2,287 Seagen Inc. Common Stock shares in Q3 2022, an estimated $404K.
  • Harfst & Associates first reported a position in Seagen Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • Harfst & Associates's Seagen Inc. Common Stock position peaked at $592K in Q3 2021.
  • 539 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2022.

Based on Harfst & Associates's 13F filing for Q3 2022, filed 28 Oct 2022.